Literature DB >> 31350831

Histotoxic Clostridial Infections.

Masahiro Nagahama1, Masaya Takehara1, Julian I Rood2.   

Abstract

The pathogenesis of clostridial myonecrosis or gas gangrene involves an interruption to the blood supply to the infected tissues, often via a traumatic wound, anaerobic growth of the infecting clostridial cells, the production of extracellular toxins, and toxin-mediated cell and tissue damage. This review focuses on host-pathogen interactions in Clostridium perfringens-mediated and Clostridium septicum-mediated myonecrosis. The major toxins involved are C. perfringens α-toxin, which has phospholipase C and sphingomyelinase activity, and C. septicum α-toxin, a β-pore-forming toxin that belongs to the aerolysin family. Although these toxins are cytotoxic, their effects on host cells are quite complex, with a range of intracellular cell signaling pathways induced by their action on host cell membranes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 31350831     DOI: 10.1128/microbiolspec.GPP3-0024-2018

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  6 in total

1.  Rapidly progressive and fatal distant spontaneous gas gangrene due to Clostridium septicum after biopsy of malignant cecal mass.

Authors:  Geetha Sivasubramanian
Journal:  IDCases       Date:  2021-04-22

2.  Distant myonecrosis by atraumatic Clostridium septicum infection in a patient with metastatic breast cancer.

Authors:  Kelsey M Gray; Pablo L Padilla; Blake Sparks; Peter Dziewulski
Journal:  IDCases       Date:  2020-05-05

Review 3.  WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections.

Authors:  Massimo Sartelli; Federico Coccolini; Yoram Kluger; Ervis Agastra; Fikri M Abu-Zidan; Ashraf El Sayed Abbas; Luca Ansaloni; Abdulrashid Kayode Adesunkanmi; Goran Augustin; Miklosh Bala; Oussama Baraket; Walter L Biffl; Marco Ceresoli; Elisabetta Cerutti; Osvaldo Chiara; Enrico Cicuttin; Massimo Chiarugi; Raul Coimbra; Daniela Corsi; Francesco Cortese; Yunfeng Cui; Dimitris Damaskos; Nicola de'Angelis; Samir Delibegovic; Zaza Demetrashvili; Belinda De Simone; Stijn W de Jonge; Stefano Di Bella; Salomone Di Saverio; Therese M Duane; Paola Fugazzola; Joseph M Galante; Wagih Ghnnam; George Gkiokas; Carlos Augusto Gomes; Ewen A Griffiths; Timothy C Hardcastle; Andreas Hecker; Torsten Herzog; Aleksandar Karamarkovic; Vladimir Khokha; Peter K Kim; Jae Il Kim; Andrew W Kirkpatrick; Victor Kong; Renol M Koshy; Kenji Inaba; Arda Isik; Rao Ivatury; Francesco M Labricciosa; Yeong Yeh Lee; Ari Leppäniemi; Andrey Litvin; Davide Luppi; Ronald V Maier; Athanasios Marinis; Sanjay Marwah; Cristian Mesina; Ernest E Moore; Frederick A Moore; Ionut Negoi; Iyiade Olaoye; Carlos A Ordoñez; Mouaqit Ouadii; Andrew B Peitzman; Gennaro Perrone; Tadeja Pintar; Giuseppe Pipitone; Mauro Podda; Kemal Raşa; Julival Ribeiro; Gabriel Rodrigues; Ines Rubio-Perez; Ibrahima Sall; Norio Sato; Robert G Sawyer; Vishal G Shelat; Michael Sugrue; Antonio Tarasconi; Matti Tolonen; Bruno Viaggi; Andrea Celotti; Claudio Casella; Leonardo Pagani; Sameer Dhingra; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2022-01-15       Impact factor: 5.469

4.  The Agr-Like Quorum-Sensing System Is Important for Clostridium perfringens Type A Strain ATCC 3624 To Cause Gas Gangrene in a Mouse Model.

Authors:  Mauricio A Navarro; Jihong Li; Juliann Beingesser; Bruce A McClane; Francisco A Uzal
Journal:  mSphere       Date:  2020-06-17       Impact factor: 5.029

5.  Clostridial Gas Gangrene - A Rare but Deadly Infection: Case series and Comparison to Other Necrotizing Soft Tissue Infections.

Authors:  Maximilian Leiblein; Nils Wagner; Elisabeth H Adam; Johannes Frank; Ingo Marzi; Christoph Nau
Journal:  Orthop Surg       Date:  2020-10-04       Impact factor: 2.071

6.  Isolation of Alpha-Toxin-Deficient Clostridium perfringens Type F from Sewage Influents and Effluents.

Authors:  Keita Yanagimoto; Eiji Haramoto
Journal:  Microbiol Spectr       Date:  2021-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.